As shutdown ends, dubious CDC panel gets back to dismantling vaccine schedule

As government operations resume, a contentious panel of vaccine advisors, appointed by Health Secretary Robert F. Kennedy, is quickly moving forward with plans to revise the federal childhood vaccination schedule. Initially set for October, a meeting has been rescheduled for December 4 and 5, as announced in a recent Federal Register notice. This session aims to cover topics including vaccine safety and the immunization schedule for children and adolescents, specifically focusing on hepatitis B vaccinations. The Advisory Committee on Immunization Practices (ACIP), which typically includes highly regarded vaccine specialists, is now facing scrutiny following the dismissal of its previous 17 members by Kennedy in June. The new panelists, numbering 12, have raised concerns due to their questionable qualifications and their alignment with anti-vaccine sentiments. In a prior meeting held in September, the group intended to propose changes to the hepatitis B vaccination recommendations but ultimately withdrew the suggestion when it was deemed unsupported by scientific data. Hepatitis B vaccinations are administered in a three-dose series, beginning at birth and continuing at one to two months, with the final dose given between six to eighteen months. This vaccine is crucial in preventing a serious liver infection that can lead to chronic health issues if contracted early in life. The initial dose at birth is especially critical, as it protects infants from a virus that can be transmitted by asymptomatic carriers. Approximately 2.4 million individuals in the United States are living with hepatitis B, and nearly half are unaware of their infection status. During the September meeting, Adam Langer, the acting principal deputy director of the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, presented extensive data emphasizing the safety of the hepatitis B vaccine, including the birth dose, which has not been associated with significant safety concerns.